Dr. Claudia Hesselmann, a chemist by training with a PhD in molecular biology, has twenty years of expertise in the early phases of drug development. Her experience includes co-founding and holding management positions in various companies. Her extensive background, along with her first-hand knowledge of the industry, led her to co-found ARENSIA Exploratory Medicine in Düsseldorf, Germany. Her primary aim is to contribute innovative approaches that substantially accelerate the drug development process and enable more agile patient access to novel therapeutics.